There are 2789 resources available
844P - Barriers to treatment for patients with lymphoma across Europe: Upper middle income versus high income countries
Presenter: Olufunmilayo Bamigbola
Session: ePoster Display
845P - Incidence of second primary malignancies (SPM) in relapsed/refractory (r/r) B-cell non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM) patients in England
Presenter: Montserrat Miret
Session: ePoster Display
846P - Predictive and prognostic values of serum VEGF in patients with multiple myelomas receiving bortezomib-based therapy
Presenter: Salah Khallaf
Session: ePoster Display
847P - The utility of serum amylase as a clinical marker in patients with multiple myeloma
Presenter: Chetana Panthula
Session: ePoster Display
Resources:
Abstract
849P - Demographics of Langerhans cell histiocytosis patients who died during the 2010-2017
Presenter: Sai Giridhar Gundepalli
Session: ePoster Display
850P - Acute lymphoblastic leukemia patients receiving prophylactic cranial irradiation by volumetric modulated ARC therapy with hippocampal sparing: Dosimetric analysis
Presenter: Ambedkar Yadala
Session: ePoster Display
915P - Carboplatin in combination with three weekly paclitaxel as first line therapy in patients with recurrent/metastatic head and neck cancers: A regional cancer center experience
Presenter: Pooja Babbar
Session: ePoster Display
916P - Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Presenter: Leonardo Muratori
Session: ePoster Display
853P - PRAME expression and ImmTAC TCR bispecific sensitivity in acute myeloid leukaemia in the presence and absence of the hypomethylating agent decitabine
Presenter: Camille Britton-Rivet
Session: ePoster Display